Santhera Pharmaceuticals Holding AG (XSWX:SANN) Other Operating Expense : CHF-0.13 Mil (TTM As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Santhera Pharmaceuticals Holding AG Other Operating Expense?

Santhera Pharmaceuticals Holding AG's Other Operating Expense for the six months ended in Jun. 2023 was CHF-0.04 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was CHF-0.13 Mil.

Santhera Pharmaceuticals Holding AG's quarterly Other Operating Expense declined from Jun. 2022 (CHF-0.01 Mil) to Dec. 2022 (CHF-0.09 Mil) but then increased from Dec. 2022 (CHF-0.09 Mil) to Jun. 2023 (CHF-0.04 Mil).

Santhera Pharmaceuticals Holding AG's annual Other Operating Expense increased from Dec. 2020 (CHF-0.49 Mil) to Dec. 2021 (CHF-0.25 Mil) and increased from Dec. 2021 (CHF-0.25 Mil) to Dec. 2022 (CHF-0.10 Mil).

Santhera Pharmaceuticals Holding AG Other Operating Expense Historical Data

The historical data trend for Santhera Pharmaceuticals Holding AG's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santhera Pharmaceuticals Holding AG Other Operating Expense Chart

Santhera Pharmaceuticals Holding AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Operating Expense

Get a 7-Day Free Trial

-0.11

-0.16

-0.49

-0.25

-0.10

Santhera Pharmaceuticals Holding AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Operating Expense	Get a 7-Day Free Trial															0.03	-0.28	-0.01	-0.09	-0.04

Santhera Pharmaceuticals Holding AG Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.13 Mil.

Santhera Pharmaceuticals Holding AG Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Santhera Pharmaceuticals Holding AG's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Santhera Pharmaceuticals Holding AG (XSWX:SANN) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SPHDF:USA SANNz:UK

Address

Hohenrainstrasse 24, Pratteln, CHE, 4133

Website

https://www.santhera.com

Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area that includes many orphan and niche indications with high unmet medical needs. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary, and neuromuscular diseases. The company derives most of its revenue from the European Union.

Santhera Pharmaceuticals Holding AG (XSWX:SANN) Headlines

No Headlines